LBRX Research Development from 2010 to 2026

LBRX Stock   19.36  0.43  2.17%   
LB Pharmaceuticals Research Development yearly trend continues to be fairly stable with very little volatility. Research Development is likely to outpace its year average in 2026. During the period from 2010 to 2026, LB Pharmaceuticals Research Development regression line of annual values had r-squared of  0.47 and arithmetic mean of  11,597,037. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
58.8 M
Current Value
61.8 M
Quarterly Volatility
21.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LB Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LB Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 800, Net Interest Income of 2.1 M or Interest Income of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. LBRX financial statements analysis is a perfect complement when working with LB Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with LBRX Stock
Check out the analysis of LB Pharmaceuticals Correlation against competitors.

Latest LB Pharmaceuticals' Research Development Growth Pattern

Below is the plot of the Research Development of LB Pharmaceuticals Common over the last few years. It is LB Pharmaceuticals' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LB Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

LBRX Research Development Regression Statistics

Arithmetic Mean11,597,037
Geometric Mean2,892,574
Coefficient Of Variation189.14
Mean Deviation16,119,473
Median1,346,000
Standard Deviation21,934,594
Sample Variance481.1T
Range60.4M
R-Value0.69
Mean Square Error271T
R-Squared0.47
Significance0
Slope2,984,052
Total Sum of Squares7698T

LBRX Research Development History

202661.8 M
202558.8 M
202451.2 M
20237.8 M

About LB Pharmaceuticals Financial Statements

LB Pharmaceuticals investors use historical fundamental indicators, such as LB Pharmaceuticals' Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LB Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development58.8 M61.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LBRX Stock Analysis

When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.